Increased colon tumor susceptibility in azoxymethane treated CEABAC transgenic mice

Carcinogenesis

Volumn 27, Issue 9, 2006, Pages 1909-1916

  Chan, Carlos H F ^a   Cook, Denise ^a   Stanners, Clifford P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BETA CATENIN; CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER SUSCEPTIBILITY; CELL SURFACE; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE MUTATION; GENETIC PREDISPOSITION; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ANTIGENS, CD; AZOXYMETHANE; BETA CATENIN; CARCINOGENS; CELL ADHESION MOLECULES; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; MICE; MICE, TRANSGENIC; MUTATION;

EID: 33747879883     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl040     Document Type: Article

References (46)

1. Hammarstrom,S., Olsen,A., Teglund,S. and Baranov,V. (1998) The nature and expression of the human CEA family. In: Stanners,C.P. (ed.), Cell Adhesion and Communication Mediated by the CEA Family: Basic and Clinical Perspectives. Harwood Academic Publishers, Amsterdam, The Netherlands, pp. 1-30.
2. Ballesta,A.M., Molina,R., Filella,X., Jo,J. and Gimenez,N. (1995) Carcinoembryonic antigen in staging and follow-up of patients with solid tumors. Tumour Biol., 16, 32-41.
3. Chevinsky,A.H. (1991) CEA in tumors of other than colorectal origin. Semin. Surg. Oncol., 7, 162-166.
4. Jantscheff,P., Terracciano,L., Lowy,A. et al. (2003) Expression of CEACAM6 in resectable colorectal cancer: A factor of independent prognostic significance. J. Clin. Oncol., 21, 3638-3646.
5. Eidelman,F.J., Fuks,A., DeMarte,L., Taheri,M. and Stanners,C.P. (1993) Human carcinoembryonic antigen, an intercellular adhesion molecule, blocks fusion and differentiation of rat myoblasts. J. Cell. Biol., 123, 467-475.
6. Rojas,M., DeMarte,L., Screaton,R.A. and Stanners,C.P. (1996) Radical differences in functions of closely related members of the human carcinoembryonic antigen gene family. Cell Growth Differ., 7, 655-662.
7. Ilantzis,C., DeMarte,L., Screaton,R.A. and Stanners,C.P. (2002) Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia, 4, 151-163.
8. Duxbury,M.S., Ito,H., Zinner,M.J., Ashley,S.W. and Whang,E.E. (2004) CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene, 23, 465-473.
9. Ordonez,C., Screaton,R.A., Ilantzis,C. and Stanners,C.P. (2000) Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res., 60, 3419-3424.
10. Soeth,E., Wirth,T., List,H.J., Kumbhani,S., Petersen,A., Neumaier,M., Czubayko,F. and Juhl,H. (2001) Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells. Clin. Cancer Res., 7, 2022-2030.
11. Tobi,M., Chintalapani,S., Kithier,K. and Clapp,N. (2000) Carcinoembryonic antigen family of adhesion molecules in the cotton top tamarin (Saguinus oedipus). Cancer Lett., 157, 45-50.
12. Zhou,G.Q., Zhang,Y. and Hammarstrom,S. (2001) The carcinoembryonic antigen (CEA) gene family in non-human primates. Gene, 264, 105-112.
13. Clarke,P., Mann,J., Simpson,J.F., Rickard-Dickson,K. and Primus,F.J. (1998) Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy. Cancer Res., 58, 1469-1477.
14. Eades-Perner,A.M., van der Putten,H., Hirth,A., Thompson,J., Neumaier,M., von Kleist,S. and Zimmermann,W. (1994) Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern. Cancer Res., 54, 4169-4176.
15. Thompson,J.A., Eades-Perner,A.M., Ditter,M., Muller,W.J. and Zimmermann,W. (1997) Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: An animal model for CEA-directed tumor immunotherapy. Int. J. Cancer, 72, 197-202.
16. Chan,C.H. and Stanners,C.P. (2004) Novel mouse model for carcinoembryonic antigen-based therapy. Mol. Ther., 9, 775-785.
17. 6-methylguanine-DNA methyltransferases. J. Biol. Chem., 269, 730-733.
18. Hickman,M.J. and Samson,L.D. (2004) Apoptotic signaling in response to a single type of DNA lesion, O(6)-methylguanine. Mol. Cell, 14, 105-116.
19. Wali,R.K., Skarosi,S., Hart,J., Zhang,Y., Dolan,M.E., Moschel,R.C., Nguyen,L., Mustafi,R., Brasitus,T.A. and Bissonnette,M. (1999) Inhibition of O(6)-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats. Carcinogenesis, 20, 2355-2360.
20. Yamada,Y., Oyama,T., Hirose,Y., Hara,A., Sugie,S., Yoshida,K., Yoshimi,N. and Mori,H. (2003) Beta-Catenin mutation is selected during malignant transformation in colon carcinogenesis. Carcinogenesis, 24, 91-97.
21. Okamoto,M., Ohtsu,H., Kominami,R. and Yonekawa,H. (1995) Mutational and LOH analyses of p53 alleles in colon tumors induced by 1,2-dimethylhydrazine in F1 hybrid mice. Carcinogenesis, 16, 2659-2666.
22. Erdman,S.H., Wu,H.D., Hixson,L.J., Ahnen,D.J. and Gerner,E.W. (1997) Assesment of mutations in Ki-ras and p53 in colon cancers from azoxymethane- and dimethylhydrazine-treated rats. Mol. Carcinog., 19, 137-144.
23. Ilantzis,C., Jothy,S., Alpert,L.C., Draber,P. and Stanners,C.P. (1997) Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis. Lab. Invest., 76, 703-716.
24. Sambrook,J. and Russell,D.W. (2001) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
25. Singh,P., Velasco,M., Given,R., Varro,A. and Wang,T.C. (2000) Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen. Gastroenterology, 119, 162-171.
26. Thompson,J., Seitz,M., Chastre,E., Ditter,M., Aldrian,C., Gespach,C. and Zimmermann,W. (1997) Down-regulation of carcinoembryonic antigen family member 2 expression is an early event in colorectal tumorigenesis. Cancer Res., 57, 1776-1784.
27. Jothy,S., Slesak,B., Harlozinska,A., Lapinska,J., Adamiak,J. and Rabczynski,J. (1996) Field effect of human colon carcinoma on normal mucosa: Relevance of carcinoembryonic antigen expression. Tumour Biol., 17, 58-64.
28. Takahashi,H. and Wakabayashi,K. (2004) Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci., 95, 475-480.
29. Yuen,S.T., Davies,H., Chan,T.L. et al. (2002) Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res., 62, 6451-6455.
30. Soussi,T. and Béroud,C. (2003) Significant of TP53 mutations in human cancer: A critical analysis of mutations at CpG dinucleotides. Hum. Mutat., 21, 192-200.
31. Wirth,T., Soeth,E., Czubayko,F. and Juhl,H. (2002) Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth. Clin. Exp. Metastasis, 19, 155-160.
32. Screaton,R.A., Penn,L.Z. and Stanners,C.P. (1997) Carcinoembryonic antigen, a human tumor marker, cooperates with Myc and Bcl-2 in cellular transformation. J. Cell. Biol., 137, 939-952.
33. Bird,R.P. (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93, 55-71.
34. Boucher,D., Cournoyer,D., Stanners,C.P. and Fuks,A. (1989) Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue. Cancer Res., 49, 847-852.
35. Tran,R., Kashmiri,S.V., Kantor,J., Greiner,J.W., Pestka,S., Shively,J.E. and Schlom,J. (1988) Correlation of DNA hypomethylation with expression of carcinoembryonic antigen in human colon carcinoma cells. Cancer Res., 48, 5674-5679.
36. Verhaar,M.J., Damen,C.A., Zonnenberg,B.A. and Blijham,G.H. (1999) In vitro upregulation of carcinoembryonic antigen expression by combinations of cytokines. Cancer Lett., 139, 67-73.
37. Hinoda,Y., Saito,T., Takahashi,H., Itoh,F., Adachi,M. and Imai,K. (1997) Induction of nonspecific cross-reacting antigen mRNA by interferon-gamma and anti-fibronectin receptor antibody in colon cancer cells. J. Gastroenterol., 32, 200-205.
38. Kantor,J., Tran,R., Greiner,J., Pestka,S., Fisher,P.B., Shively,J.E. and Schlom,J. (1989) Modulation of carcinoembryonic antigen messenger RNA levels in human colon carcinoma cells by recombinant human gamma-interferon. Cancer Res., 49, 2651-2655.
39. Smyth,M.J., Cretney,E., Kershaw,M.H. and Hayakawa,Y. (2004) Cytokines in cancer immunity and immunotherapy. Immunol. Rev., 202, 275-293.
40. Blum,C.A., Xu,M., Orner,G.A., Fong,A.T., Bailey,G.S., Stoner,G.D., Horio,D.T. and Dashwood,R.H. (2001) Beta-catenin mutation in rat colon tumors initated by 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol. Carcinogenesis, 22, 315-320.
41. Koesters,R., Hans,M.A., Benner,A., Prosst,R., Boehm,J., Gahlen,J. and von Knebel Doeberitz,M. (2001) Predominant mutation of codon 41 of the beta-catenin proto-oncogene in rat colon tumors induced by 1,2-dimenthylhydrazine using a complete carcinogenic protocol. Carcinogenesis, 22, 1885-2001.
42. Liu,C., Li,Y., Semenov,M., Han,C., Baeg,G., Tan,Y., Zhang,Z., Lin,X. and He,X. (2002) Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell, 108, 837-847.
43. Aberle,H., Bauer,A., Stappert,J., Kispert,A. and Kemler,R. (1997) Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J, 16, 3797-3804.
44. Provost,E., McCabe,A., Stern,J., Lizardi,I., D'Aquila,T.G. and Rimm,D.L. (2005) Functional correlates of mutation of the Asp32 and Gly34 residues of beta-catenin. Oncogene, 24, 2667-2676.
45. Al-Fageeh,M., Li,Q., Dashwood,W.M., Myzak,M.C. and Dashwood,R.H. (2004) Phosphorylation of oncogenic mutants of beta-catenin containing substitutions at Asp32. Oncogene, 23, 4839-4846.
46. Kishimoto,Y., Morisawa,T., Hosoda,A., Shiota,G., Kawasaki,H. and Hasegawa,J. (2002) Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. J. Exp. Clin. Cancer Res., 21, 203-211.